Original language | English |
---|---|
Article number | A21 |
Journal | PLoS ONE |
Volume | 8 |
Issue number | 8 |
DOIs |
|
State | Published - 27 Aug 2013 |
Bibliographical note
Funding Information:There was information omitted from the Funding statement. The correct version of the Funding statement is available below: This work was supported by a service development grant from the Jewish Federation of New York and a research grant MH071651 from the National Institute of Mental Health. Dr. YIS received an investigator-initiated grant from Lundbeck Pharmaceuticals for this study and for a collaborative study (principal investigator: Dr. Joseph Zohar) entitled “Prevention of PTSD by Escitalopram.” The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Funding
There was information omitted from the Funding statement. The correct version of the Funding statement is available below: This work was supported by a service development grant from the Jewish Federation of New York and a research grant MH071651 from the National Institute of Mental Health. Dr. YIS received an investigator-initiated grant from Lundbeck Pharmaceuticals for this study and for a collaborative study (principal investigator: Dr. Joseph Zohar) entitled “Prevention of PTSD by Escitalopram.” The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Funders | Funder number |
---|---|
Jewish Federation of New York | MH071651 |
National Institute of Mental Health |